Background: Public health advisories have warned that the use of atypical antipsychotic
medications increases the risk of death among elderly patients. We assessed the short-term …

Background Recently, the Food and Drug Administration (FDA) issued an advisory stating
that atypical antipsychotic medications increase mortality among elderly patients. However …

Purpose To estimate the association between use of typical and atypical antipsychotics and
all‐cause mortality in a population of demented outpatients. Methods The study cohort …

BackgroundAll antipsychotic medications carry warnings of increased mortality for older
adults, but little is known about comparative mortality risks between individual agents …

OBJECTIVES: To investigate the potential mechanisms through which conventional
antipsychotic medication (APM) might act, the specific causes of death in elderly patients …

Background: Antipsychotic drugs are widely used to manage behavioral and psychological
symptoms in dementia despite concerns about their safety. Objective: To examine the …

Objective To investigate short-and long-term mortality risk associated with the use of
antipsychotics in dementia outpatients, assessing the risk over specific time frames and …

Objective The purpose of this study was to assess trends in utilization and costs of
antipsychotic drugs among a population of older adults over time, with respect to the …

Background In April 2005, the US Food and Drug Administration (FDA) issued an advisory
and subsequent black box warning regarding the risks of atypical anti psychotic use among …

It is almost ten years since the Banerjee 2009 report established that inappropriate
prescribing of antipsychotics in the elderly was occurring in the UK and such patients had an …